This inventor holds 1 USPTO granted patent. Top assignee: Chevron Research Company. Active years: 1989.
Company Filing History:
Years Active: 1989
Title: Joseph R Riden: Innovator in Tumor Treatment
Introduction
Joseph R Riden is an accomplished inventor based in Overland Park, Kansas. He has made significant contributions to the field of cancer treatment through his innovative research and development. His work focuses on the use of specific chemical compounds to target tumor cells effectively.
Latest Patents
Joseph R Riden holds a patent for the use of tricyclodecene-3,4,7,8-tetracarboxylic acid derivatives. The patent describes a method that involves administering these derivatives to tumor-containing animals. The preferred compound is one that has a specific structural formula or a pharmaceutically acceptable salt thereof. This innovative approach aims to enhance the effectiveness of cancer treatments.
Career Highlights
Riden is associated with Chevron Research Company, where he has been instrumental in advancing research in pharmaceutical applications. His work has contributed to the development of new methods for treating tumors, showcasing his dedication to improving patient outcomes.
Collaborations
Riden has collaborated with Ralph P Neighbors, further enhancing the research efforts at Chevron Research Company. Their combined expertise has led to advancements in the understanding and treatment of cancer.
Conclusion
Joseph R Riden's contributions to cancer treatment through his innovative patent demonstrate his commitment to advancing medical science. His work continues to inspire future research in the field.